PMV Pharmaceuticals annual current ratio
2019
2020
2021
2022
2023
2024
2025
PMV Pharmaceuticals Current Ratio Growth & History (PMVP)
PMV Pharmaceuticals's current ratio was 10.09 for fiscal 2025.
View full PMV Pharmaceuticals company overviewPMV Pharmaceuticals annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 10.09 | −2.13 | −17.42% |
| 2024 | 2024-12-31 | 12.22 | −2.56 | −17.32% |
| 2023 | 2023-12-31 | 14.78 | −8.02 | −35.17% |
| 2022 | 2022-12-31 | 22.80 | −1.85 | −7.52% |
| 2021 | 2021-12-31 | 24.66 | −32.25 | −56.67% |
| 2020 | 2020-12-31 | 56.90 | 34.33 | +152.10% |
| 2019 | 2019-12-31 | 22.57 | — | — |
PMV Pharmaceuticals quarterly current ratio
Q4.19
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 7.70 | −4.82 | −38.47% |
| Q1 2026 | 2026-03-31 | 11.14 | −5.61 | −33.49% |
| Q4 2025 | 2025-12-31 | 10.09 | −2.13 | −17.42% |
| Q3 2025 | 2025-09-30 | 10.76 | −3.22 | −23.00% |
| Q2 2025 | 2025-06-30 | 12.52 | −6.70 | −34.85% |
| Q1 2025 | 2025-03-31 | 16.75 | −0.04 | −0.22% |
| Q4 2024 | 2024-12-31 | 12.22 | −2.56 | −17.32% |
| Q3 2024 | 2024-09-30 | 13.98 | −5.18 | −27.02% |
| Q2 2024 | 2024-06-30 | 19.22 | 2.58 | +15.53% |
| Q1 2024 | 2024-03-31 | 16.79 | −5.24 | −23.78% |
| Q4 2023 | 2023-12-31 | 14.78 | −8.02 | −35.17% |
| Q3 2023 | 2023-09-30 | 19.16 | −3.59 | −15.79% |
| Q2 2023 | 2023-06-30 | 16.63 | −8.13 | −32.82% |
| Q1 2023 | 2023-03-31 | 22.03 | −2.62 | −10.64% |
| Q4 2022 | 2022-12-31 | 22.80 | −1.85 | −7.52% |
| Q3 2022 | 2022-09-30 | 22.75 | −13.87 | −37.87% |
| Q2 2022 | 2022-06-30 | 24.76 | −18.29 | −42.49% |
| Q1 2022 | 2022-03-31 | 24.65 | −33.14 | −57.35% |
| Q4 2021 | 2021-12-31 | 24.66 | −32.25 | −56.67% |
| Q3 2021 | 2021-09-30 | 36.62 | −31.62 | −46.34% |
| Q2 2021 | 2021-06-30 | 43.05 | — | — |
| Q1 2021 | 2021-03-31 | 57.79 | — | — |
| Q4 2020 | 2020-12-31 | 56.90 | 34.33 | +152.10% |
| Q3 2020 | 2020-09-30 | 68.24 | — | — |
| Q4 2019 | 2019-12-31 | 22.57 | — | — |
PMV Pharmaceuticals current ratio trends
Over the last five fiscal years, PMV Pharmaceuticals's current ratio decreased from 56.90 to 10.09, a change of −46.81. The latest reported quarter, Q2 2026, shows 7.70.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review PMV Pharmaceuticals source filings ↗